The Cornell Daily Sun (https://cornellsun.com/tag/weill-cornell-medicine/)
Researchers at Weill Cornell Medicine and Cornell University are collaborating on a project to investigate virtual reality as a tool to address loneliness and social isolation among older adults.
New Weill Cornell and Columbia University research shows effects of monkeypox on patients with HIV.
The University announced on Thursday that Dr. Robert A. Harrington, the Arthur L. Bloomfield Professor of Medicine and chair of the department of medicine at Stanford University, has been named the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine.
Researchers at the Chen Lab, led by Prof. Shuibing Chen, cell and developmental biology, recently published a study identifying a key gene in the pathology of COVID-19. The gene, CIART, helps establish the viral infection that causes COVID-19, also known as SARS-CoV-2.
Dr. Jason Spector, plastic and reconstructive surgery, and his lab at Weill Cornell Medicine published a study on March 8 that described a breast reconstruction technique utilizing a 3D-printed scaffold. The newly developed process aims to achieve softer, more natural and higher quality reconstructed nipples for breast cancer patients after mastectomies.
Researchers of the Melnick Lab recently published a study identifying a key mutation that disrupts the B-cell natural selection process during immune response, leading to aggressive diffuse large B-cell lymphoma within the body.
Autophagy, the process by which the body recycles damaged cell parts into fully functioning cell parts, may be dampened in women with postpartum depression, according to a recent Cornell Weill study done in collaboration with John Hopkins University School of Medicine and the University of Virginia Health.
Scientists at Weill Cornell Medicine have finally found a way to correlate mutations with observable characteristics in human cells, taking a step towards understanding how diversified mutations in cells may lead to disease.
On Feb. 8, a new study on the multiple sclerosis drug siponimod conducted by researchers from Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center was published in Nature Communications. The study analyzed the drug’s shape and interactions in the body, allowing researchers to understand how to lessen the drug’s side effects, such as heart and liver problems, during treatment for MS patients.
Cornell Weill scientists have recently developed a pipeline which creates direct access to singular genes of the organisms within the gut microbiome, advancing the foundational understanding of diseases within the human body as these singular genes can be manipulated and their effects observed.